(Louis) Legend of the Bluebonnet, The

by American Printing House for the Blind

$60.00

Ready to use A large-print book requires no setup, configuration, or professional guidance — open and read. Self_serve is appropriate.

Last verified May 24, 2026 · classified May 24, 2026

What it is

Summary

AI-generated from vendor-published content · May 24, 2026

This is a large-print edition of 'The Legend of the Bluebonnet' by Tomie dePaola, produced by the American Printing House for the Blind (APH) for students and readers with low vision. The enlarged text reduces eye strain and makes independent reading accessible for someone who can't comfortably use standard print but doesn't rely on braille. It's a complete, ready-to-use book — no devices, apps, or setup required. Federal Quota funds are available for eligible students, meaning many school districts can obtain this at no direct cost through APH's quota allocation system. As a single picture book title, this covers one story only; it's not a series package or reading program.

Quick Facts Catalog facts · auto-generated
Age range
ComplexityReady to use
Price$60.00
Funding
  • Out of pocket
  • School district
VerifiedMay 24, 2026
ClassifiedMay 24, 2026 · confidence: high

What Setup Looks Like

  • Out of the box
    Open and read — no setup required.

Getting it

Many states lend devices like this for free trial periods — find your state's AT lending program.

Where to Get It

aph Visit
$60.00

Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →

Wondering how equipment like this gets paid for? See the official funding programs in your state.

Sources & fine print

Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blindview on vendor site; last verified May 24, 2026.

Classification & description AI-generated from vendor-published content on May 24, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.